Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NeutrArt

K-Number: K221481 · 2022-09-23

Decision Date2022-09-23
Product CodeFPA
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

NeutrArt is the device name listed in this FDA 510(k) record. The listed applicant is Asset Medikal Tasarim As.. It received FDA 510(k) clearance on 2022-09-23 under 510(k) number K221481. The device is classified under product code FPA. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NeutrArt?

NeutrArt is a medical device that received FDA 510(k) clearance on 2022-09-23. The listed applicant is Asset Medikal Tasarim As.. The 510(k) number is K221481.

When did NeutrArt receive FDA 510(k) clearance?

NeutrArt received FDA 510(k) clearance on 2022-09-23, under 510(k) number K221481.

Who is the listed applicant for NeutrArt?

The FDA 510(k) record lists Asset Medikal Tasarim As. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NeutrArt?

The FDA product code for NeutrArt is FPA.

Other records listing Asset Medikal Tasarim As. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: FPA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.